Abnormal chromosome 8 copy number in cytological smears from breast carcinomas detected by means of fluorescence in situ hybridization (FISH)

被引:15
作者
Bofin, AM [1 ]
Ytterhus, B
Fjosne, HE
Hagmar, BM
机构
[1] Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med, N-7006 Trondheim, Norway
[2] Univ Trondheim Hosp, Dept Endocrine Surg, Trondheim, Norway
[3] Natl Univ Hosp, Inst Lab Med, Oslo, Norway
关键词
fluorescence in situ hybridization; chromosome analysis; fine needle aspiration cytology; breast; histological grade;
D O I
10.1046/j.1365-2303.2003.01132.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Numerical change in chromosome 8 is an acquired abnormality associated with high clinical stage and may be involved in the conversion of carcinoma in situ in the breast to invasive carcinoma. Fine needle aspiration smears from 53 cases of breast carcinoma were hybridized with centromeric probes for chromosome 8 and the X chromosome. Thirty-eight cases revealed chromosome 8 copy gain. Of the 45 grade II and III tumours, 28 showed polysomy (>3 signals) and six showed trisomy. Of the eight grade I tumours, four were trisomic, none were polysomic. There were only two cases of chromosome 8 copy loss (one each of grade I and III). X chromosome polysomy was also a frequent finding although the signal counts were similar to those for chromosome 8 in only a few cases. Chromosome 8 polysomy occurs frequently in breast carcinoma and high copy number (>3) is associated with high malignancy grade.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 24 条
[1]   DNA PLOIDY IN INTRADUCTAL BREAST CARCINOMAS [J].
AASMUNDSTAD, TA ;
HAUGEN, OA .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (09) :956-959
[2]   Trisomy 8 in embryonal rhabdomyosarcoma detected by fluorescence in situ hybridization [J].
Afify, A ;
Mark, HFL .
CANCER GENETICS AND CYTOGENETICS, 1999, 108 (02) :127-132
[3]   Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer [J].
Afify, A ;
Bland, KI ;
Mark, HFL .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (02) :201-208
[4]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[5]   Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution [J].
Buerger, H ;
Mommers, EC ;
Littmann, R ;
Simon, R ;
Diallo, R ;
Poremba, C ;
Dockhom-Dworniczak, B ;
van Diest, PJ ;
Boecker, W .
JOURNAL OF PATHOLOGY, 2001, 194 (02) :165-170
[6]   TRISOMY-8 AS A RECURRENT CLONAL ABNORMALITY IN BREAST-CANCER [J].
BULLERDIEK, J ;
LEUSCHNER, E ;
TAQUIA, E ;
BONK, U ;
BARTNITZKE, S .
CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) :64-67
[7]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[8]  
HEDLEY DW, 1987, CANCER RES, V47, P4729
[9]   Stage I and stage II infiltrating ductal carcinoma of the breast analyzed for chromosome 8 copy number using fluorescent in situ hybridization [J].
Mark, HFL ;
Taylor, W ;
Afify, A ;
Riera, D ;
Rausch, M ;
Huth, A ;
Gray, Y ;
Santoro, K ;
Bland, KI .
PATHOBIOLOGY, 1997, 65 (04) :184-189
[10]   CONSTITUTIONAL TRISOMY-8 MOSAICISM AND GESTATIONAL TROPHOBLASTIC DISEASE [J].
MARK, HFL ;
AHEARN, J ;
LATHROP, JC .
CANCER GENETICS AND CYTOGENETICS, 1995, 80 (02) :150-154